Sex Drive After Hysterectomy: What Four Meta-Analyses Found
Share
Sex drive after hysterectomy, measured across every pooled analysis that has looked, does not change significantly on average. Two independent research teams reached that same landing point from two different study pools. Dedden and colleagues pooled 32 studies covering 4,054 patients and found no significant change in overall sexual function, whichever surgical route was used. Kazemi and colleagues pooled 11 studies and reported a standardized mean difference of 0.08 with a 95% confidence interval running from -0.38 to 0.55, an interval that sits squarely across zero. Two more recent reviews reached compatible conclusions. The same papers also say something almost nobody repeats: women who had problems before the operation often still report them afterwards.
- Dedden and colleagues analyzed 32 articles comprising 4,054 patients and found hysterectomy was not associated with significant change in overall sexual function irrespective of surgical route. Removing the cervix made no significant difference.
- Kazemi and colleagues pooled 11 studies and reported a standardized mean difference of 0.08, 95% confidence interval -0.38 to 0.55, with heterogeneity of 96.8% between studies. Their conclusion was that hysterectomy caused by benign diseases does not change the sexual function significantly.
- Kazemi's meta-regression found that for each month of distance from hysterectomy, women's sexual function score increases by 0.18. Recovery in this literature is counted in months.
- Dedden describes patients tending to report potentially remaining sexual dysfunction posthysterectomy, and a 2026 review found scores stayed below the standard questionnaire cutoff throughout follow-up on every route. Problems present before surgery tend to remain after it.
- Dedden found the group without ovary removal did better on some measures of physical response, then found those differences were not replicated in studies directly comparing cases with and without it. Whether your ovaries come out is a question for your surgeon.
Figures from Dedden et al. 2023 (PMID 36857309) and Kazemi et al. 2022 (PMID 34732379).
Will I still want sex after the surgery?
On the average of the pooled evidence, yes. Four research teams have run this question through a meta-analysis, and none found the operation itself reliably takes desire away. That deserves saying plainly, because the version circulating online is far darker than the data supports.
Hysterectomy is the most common nonobstetrical medical procedure performed in US women. Harvey and colleagues put the prevalence among surveyed women at 21.4% in 2006 and 21.1% in 2016. So this is an experience shared by roughly one in five women, and the fear alongside it is close to universal: that a decision made for bleeding, or fibroids, or pain is quietly also a decision about the rest of your sex life.
If your desire was already low before the surgery date was set, the operation was never going to be the thing that lifted it. Dedden and the 2026 review by Molnar-Csendom both record that problems tend to remain after the operation. If that describes you, our guide to why your libido is so low covers the wider set of drivers, and it is the more useful place to start.
What the four meta-analyses actually found
Four pooled analyses cover this ground, using different databases, inclusion rules, and study pools. They arrive at compatible answers.
Dedden and colleagues, 2023, in The Journal of Sexual Medicine, is the largest. In the authors' own words, hysterectomy was not associated with significant change in overall sexual function irrespective of surgical route, with patients tending to report potentially remaining sexual dysfunction posthysterectomy. Cervix removal was not significantly associated with differences in magnitude of change. They rate their own study quality as moderate, note large heterogeneity, and say conclusions need cautious interpretation.
Kazemi and colleagues, 2022, in the Journal of Minimally Invasive Gynecology, carried 11 observational studies out of 5,587 records to the final analysis. The pooled standardized mean difference was 0.08, 95% confidence interval -0.38 to 0.55, heterogeneity 96.8%. Publication bias was not detected. Their conclusion: hysterectomy caused by benign diseases does not change the sexual function significantly. Women on hormone replacement therapy were excluded.
Molnar-Csendom and colleagues, 2026, in Medical Sciences, found no clinically or statistically significant improvement against baseline across all hysterectomy types, and no meaningful advantage for subtotal over total hysterectomy. The line that matters most for a worried reader is a different one: questionnaire totals sat at the level of sexual dysfunction at baseline and remained below the established cutoff of 26.55 throughout follow-up on every route. Scores low going in were still low coming out.
Ouyang and colleagues, 2026, in the same journal, is the narrowest by design, restricted to premenopausal women having minimally invasive surgery with the ovaries preserved. That strips out two of the biggest confounders in the older literature. The total questionnaire score moved 1.54 points toward better function, 95% confidence interval 0.25 to 2.83. The authors call that small, statistically significant, and not likely clinically significant, and rate the evidence low.
| Review | What it pooled | What it found | The caveat the authors attached |
|---|---|---|---|
| Dedden 2023 | 32 articles, 4,054 patients, benign non-prolapse surgery, 8 randomized trials | No significant change in overall sexual function irrespective of route. Cervix removal made no significant difference | Moderate study quality, large heterogeneity. Patients tended to report potentially remaining problems |
| Kazemi 2022 | 11 observational studies from 5,587 records, benign disease only | Standardized mean difference 0.08, 95% CI -0.38 to 0.55. Does not change the sexual function significantly | Heterogeneity of 96.8%, which is extreme. The pooled number averages studies that disagree |
| Molnar-Csendom 2026 | 34 reviewed, 16 pooled, 2,341 patients, all indications and approaches | No clinically or statistically significant improvement against baseline. Keeping the cervix gave no measurable benefit | Scores sat below the 26.55 cutoff at baseline and stayed below it on every route |
| Ouyang 2026 | 8 studies from 1,124 records, premenopausal women, minimally invasive, ovaries preserved | Total score moved 1.54 points toward better function, 95% CI 0.25 to 2.83 | The authors call it small, statistically significant, and not likely clinically significant. Low evidence level |
Four independent teams, four different study pools
Studies each meta-analysis pooled, with its verdict on overall sexual function. Three found no significant change. One, restricted to premenopausal women with ovaries preserved, found a small change its authors call not likely clinically significant.
Sources: Dedden et al., J Sex Med 2023 (PMID 36857309); Molnar-Csendom et al., Med Sci 2026 (PMID 42506365); Kazemi et al., J Minim Invasive Gynecol 2022 (PMID 34732379); Ouyang et al., J Minim Invasive Gynecol 2026 (PMID 40451385). Bar length is evidence volume and says nothing about effect size.
"Nobody told me what to expect"
This sentence turns up in every recovery forum, and the research explains why. The literature is inconclusive at the level of the individual while being fairly settled at the level of the average. Both hold at once, and a surgeon with fifteen minutes has a hard job turning that into a sentence.
The evidence supports telling somebody this much before the operation. The average woman in these studies reported no drop in overall sexual function. Route did not decide the outcome, and neither did keeping the cervix, in Dedden's analysis and again in the 2026 review that tested it separately. Whatever was going on beforehand is the strongest predictor of what comes after, and the timeline runs longer than the six-week clearance implies.
The evidence stops short of a promise in either direction. Kazemi's heterogeneity of 96.8% means women inside that pooled number had experiences ranging from clearly better to clearly worse. A number averaging genuine disagreement is a poor prophecy for one person.
The ovary question, and why it belongs to your surgeon
This is the one place where the evidence separates the groups, and the internet version is badly overstated. Dedden compared women who had a hysterectomy without bilateral salpingo-oophorectomy, meaning both ovaries left in place, against women who had the ovaries removed at the same time. The group without ovary removal showed significantly stronger improvement on some measures of physical response. That finding did not extend to desire or to overall sexual function.
Dedden's next sentence is the one almost every summary drops. Those significant differences were not replicated within studies that directly compared cases with and without the procedure. Inside a single study, the advantage stopped showing up. A difference that appears across separate studies and disappears under direct comparison is weaker than it looks.
The authors of the largest review wrote their own clinical implication, a good one to carry into a consultation: ovary removal should not be considered if it is not medically required. That decision carries consequences well beyond sex drive and turns on your age, your diagnosis, and your family history. Talk to your surgeon about whether your ovaries need to come out. If they do, they do, and those reasons outrank anything on this page.
If ovary removal is part of your surgery, you are also entering a hormonal transition, which has its own evidence base. We cover it in low libido and menopause, and the case where hormone therapy is running and desire still has not come back is covered in HRT and a libido that is still missing.
"How long until I feel like myself again?"
Kazemi's team ran a meta-regression across their 11 studies and found that for each month of distance from hysterectomy, women's sexual function score increases by 0.18. That is the most useful number in this literature, and it is almost never quoted. Studies measuring women further out from surgery reported better scores, and the relationship held steadily enough to model.
What a slope of 0.18 per month looks like
Built on the meta-regression coefficient from Kazemi et al. 2022. The figures below are arithmetic worked from that slope. Nobody measured a score at those months, and the slope describes an average across study groups.
Source: Kazemi F, Alimoradi Z, Tavakolian S, J Minim Invasive Gynecol 2022 (PMID 34732379), meta-regression across 11 observational studies. Heterogeneity was 96.8%, so the slope describes a trend in the pooled literature and guarantees nothing about the pace of any one recovery.
Time helps, on the pooled evidence. A pooled slope also describes a research literature, so if you are four months out and nothing has shifted, you have failed no benchmark, because no benchmark for you exists.
Pelvic floor work is the one physical lever with its own evidence base, covered in pelvic floor exercises and sex drive. Anything involving your body soon after an operation goes past your surgeon first.
"Is this normal?"
Low desire is extremely common in women who have never had surgery, and that baseline is worth having in front of you before you attribute anything to an operation.
Worsley and colleagues surveyed a nationally representative, community-based sample of 2,020 Australian women aged 40 to 65 using validated instruments. Low desire turned up in 69.3%, with a 95% confidence interval of 67.3 to 71.3. Sexually related personal distress turned up in 40.5%. The two together, meeting criteria for hypoactive sexual desire dysfunction, came to 32.2%. That study had no connection to surgery at all. In their adjusted model, moderate to severe depressive symptoms carried odds of 2.69 for that diagnosis, and pain during or after intercourse carried odds of 1.63.
So a flat sex drive in a woman in her forties or fifties is a widespread experience with many contributors, and a recent operation puts a loud explanation in the room that can crowd out the quieter ones. Medication, sleep, mood, and a relationship under strain all keep operating during recovery.
This is the same trap we wrote about in normal labs and low libido. One explanation arrives, it fits part of the picture, and then it gets stretched to cover all of it. A named diagnosis does the same job, which is why the pattern shows up again in PCOS and low sex drive and in endometriosis and low sex drive.
"I feel less like a woman"
This one has almost no research behind it, and saying so is more respectful than pretending otherwise. The pooled literature measures questionnaire scores. It says nothing about what it feels like to lose an organ you have carried history and possibly grief about since you were twelve.
The research offers one useful separation. The measured outcomes came back flat, while the felt experience many women describe is anything but. Both can be true at once, because they sit on different layers. A questionnaire total holds steady while a woman's relationship with her own body has shifted a long way. That layer responds to attention in a way an average in a journal never will. Our piece on body confidence as the internal barrier to libido covers what moves it. And if the hard part is saying any of this out loud to the person you sleep next to, how to talk to your partner about low libido is the practical read.
What to ask, before the surgery and after it
A research summary is a poor substitute for a consultation with somebody holding your notes, though it can give you better questions.
- Ask whether your ovaries need to come out, and why. The largest review states that ovary removal should not be considered if it is not medically required. If yours is required, ask what that means for the months afterwards.
- Ask what the surgical route changes. In the pooled evidence, route did not decide the sexual function outcome, so a route recommended to you is recommended for other reasons worth hearing.
- Ask what a realistic timeline looks like beyond the six-week clearance. The meta-regression counts recovery in months, and knowing that saves a lot of quiet panic at week eight.
- Bring your full medication list, including anything for mood, pain, or blood pressure. Several common medicines lower desire, and that is easy to miss when an operation is already on the table.
- Say what was happening before the surgery. If desire was already low, say so plainly, because Dedden and the 2026 review both record that problems tend to remain after surgery, and that changes what to aim at afterwards.
- Ask for a referral if pain during sex is part of the picture. Pain after pelvic surgery belongs in a clinic, and waiting it out is the wrong plan.
Where a botanical supplement fits, and where it does not
Nothing in this section belongs near a surgical recovery. Healing from an operation is your surgeon's territory, and a supplement has no role in it and no evidence in it. If you are still in recovery, close this section and come back later.
There is a different situation this article keeps circling. Desire was already low before the surgery was scheduled. Recovery has finished, your surgeon has signed you off, the pooled evidence says the operation was never the thing, and desire is still where it was. That is what Dedden and the 2026 review describe when they record that problems tend to remain after the operation.
At that point the ordinary levers carry the most weight, and most of them are free. Sleep, in quantity and quality. Mood, taken seriously. Time and safety with a partner. Movement and food you enjoy. A botanical supplement sits at the small end of that list, and it belongs there.
NUUD is a botanical supplement built around desire in general. It has no role in surgery, in recovery, or in hormones, and no part in managing any medical condition. The formula is anchored by the NUUD Mushroom Complex™, with Muira Puama, Boiled Rehmannia Root, Tribulus Terrestris, and Piper Nigrum for absorption, on a timeline of roughly 30 to 60 minutes. If recovery is behind you and the everyday levers are in decent shape, that is what our women's libido support capsules are for.
"I just want to feel normal again"
You have probably been handed two unhelpful answers already. One is a shrug at a six-week check that lasted eight minutes. The other is a forum thread where the worst outcomes are loudest, because women whose sex lives carried on as before have no reason to post.
The pooled research supports neither. The average woman across four study pools did not lose her sex drive to the operation. The surgical route did not decide it. The cervix did not decide it. Whatever was already there carried forward.
So if desire was fine before and feels flat now, the evidence says give it months and keep your surgeon in the loop. And if desire was already low before any of this, the surgery answered a different question, and the one you actually have is still open and worth working on.
Keep reading
- Why is my libido so low?
- Normal labs, low libido
- Body confidence and the internal barrier to libido
- Pelvic floor exercises and sex drive
- How to talk to your partner about low libido
Frequently asked questions
Does a hysterectomy lower your sex drive?
On the pooled evidence, no. Dedden and colleagues analyzed 32 articles comprising 4,054 patients and found hysterectomy was not associated with significant change in overall sexual function irrespective of surgical route. Kazemi and colleagues pooled 11 studies and reported a standardized mean difference of 0.08 with a 95% confidence interval of -0.38 to 0.55, an interval that crosses zero, concluding that hysterectomy caused by benign diseases does not change the sexual function significantly. Two more recent reviews reached compatible conclusions. Dedden also records patients tending to report potentially remaining sexual dysfunction afterwards, and heterogeneity between studies was high, so the pooled averages describe the group and predict little about any one woman.
How long until I feel like myself again after a hysterectomy?
The pooled evidence counts this in months. Kazemi and colleagues ran a meta-regression across 11 studies and found that for each month of distance from hysterectomy, women's sexual function score increases by 0.18. That is an average slope across study groups, and no one can promise an individual trajectory from it. Heterogeneity across those studies was 96.8%. What it does mean is that the standard six-week clearance is not where the research expects things to have settled, and continued change months later fits what the literature shows. Keep your surgeon in the loop about pain, bleeding, or anything that feels wrong.
Is it normal to have no sex drive after a hysterectomy?
Low desire is common in women generally, with or without surgery in their history. Worsley and colleagues surveyed a nationally representative, community-based sample of 2,020 Australian women aged 40 to 65 and found low desire in 69.3%, sexually related personal distress in 40.5%, and both together in 32.2%. That study had no connection to surgery. Meanwhile the surgical reviews found that scores which were low before the operation tended to stay low after it. So a flat sex drive after a hysterectomy has many possible contributors, including medication, mood, sleep, pain, and a relationship under strain.
Does keeping the cervix protect your sex drive?
The pooled evidence says it makes no measurable difference. Dedden and colleagues found cervix removal was not significantly associated with differences in magnitude of change in sexual function across 32 articles. A 2026 review by Molnar-Csendom and colleagues tested the same question across 16 pooled studies covering 2,341 patients and found subtotal hysterectomy did not demonstrate a meaningful advantage over total hysterectomy, concluding that surgical approach selection should not be based on expectations of improved sexual outcomes. Which approach suits you is a surgical decision with other reasons behind it, so ask your surgeon what is driving the recommendation in your case.
Should my ovaries come out during a hysterectomy?
That is a question for your surgeon, and the evidence supports asking it directly. Dedden and colleagues found the group without ovary removal showed significantly stronger improvement on some measures of physical response than the group with it, and the same finding did not extend to desire or to overall sexual function. The authors then reported that these significant differences were not replicated within studies that directly compared cases with and without the procedure, which weakens the finding considerably. Their own clinical implication was that ovary removal should not be considered if it is not medically required. If yours is medically required, that reason outranks anything in this article.
References
- Dedden SJ, Werner MA, Steinweg J, et al. Hysterectomy and sexual function: a systematic review and meta-analysis. The Journal of Sexual Medicine. 2023;20(4):447-466. https://pubmed.ncbi.nlm.nih.gov/36857309/
- Kazemi F, Alimoradi Z, Tavakolian S. Effect of Hysterectomy due to Benign Diseases on Female Sexual Function: A Systematic Review and Meta-analysis. Journal of Minimally Invasive Gynecology. 2022;29(4):476-488. https://pubmed.ncbi.nlm.nih.gov/34732379/
- Molnar-Csendom A, Vida B, Banhidy F, et al. Assessment of Sexual Function Following Hysterectomy: A Systematic Review and Meta-Analysis. Medical Sciences (Basel). 2026;14(3):396. https://pubmed.ncbi.nlm.nih.gov/42506365/
- Ouyang C, Wang A, Briggs M, et al. Changes in Sexual Function After Minimally Invasive Hysterectomy in Reproductive-Aged Women: A Systematic Review and Meta-Analysis. Journal of Minimally Invasive Gynecology. 2026;33(1):65-73. https://pubmed.ncbi.nlm.nih.gov/40451385/
- Harvey SV, Pfeiffer RM, Landy R, et al. Trends and predictors of hysterectomy prevalence among women in the United States. American Journal of Obstetrics and Gynecology. 2022;227(4):611.e1-611.e12. https://pubmed.ncbi.nlm.nih.gov/35764133/
- Worsley R, Bell RJ, Gartoulla P, Davis SR. Prevalence and Predictors of Low Sexual Desire, Sexually Related Personal Distress, and Hypoactive Sexual Desire Dysfunction in a Community-Based Sample of Midlife Women. The Journal of Sexual Medicine. 2017;14(5):675-686. https://pubmed.ncbi.nlm.nih.gov/28499520/
This article is for general education and is not medical advice. Hysterectomy is major surgery, and only your surgeon and your medical team can advise you on whether to have it, what it should include, and how your own recovery is going. NUUD is a botanical supplement and has no role in diagnosing, treating, curing, or preventing any disease, and these statements have not been evaluated by the Food and Drug Administration. Talk with your surgeon about the operation and your recovery, and with your doctor about mood, pain, and any medication before starting a new supplement.
